QOL Stock Overview
SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for QOL from our risk checks.
SOL S.p.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €33.35 |
52 Week High | €34.95 |
52 Week Low | €23.20 |
Beta | 0.52 |
1 Month Change | 10.25% |
3 Month Change | 30.78% |
1 Year Change | 32.87% |
3 Year Change | 108.96% |
5 Year Change | 192.03% |
Change since IPO | 636.20% |
Recent News & Updates
Recent updates
Shareholder Returns
QOL | DE Chemicals | DE Market | |
---|---|---|---|
7D | -1.2% | -1.6% | 0.5% |
1Y | 32.9% | 0.9% | 1.3% |
Return vs Industry: QOL exceeded the German Chemicals industry which returned -0.3% over the past year.
Return vs Market: QOL exceeded the German Market which returned 2.3% over the past year.
Price Volatility
QOL volatility | |
---|---|
QOL Average Weekly Movement | 5.2% |
Chemicals Industry Average Movement | 4.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: QOL's share price has been volatile over the past 3 months.
Volatility Over Time: QOL's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1927 | 6,372 | Aldo Romario | www.solgroup.com |
SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. The company offers oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use and liquefied natural gas. It also provides oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids.
SOL S.p.A. Fundamentals Summary
QOL fundamental statistics | |
---|---|
Market cap | €3.14b |
Earnings (TTM) | €145.73m |
Revenue (TTM) | €1.50b |
21.6x
P/E Ratio2.1x
P/S RatioIs QOL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
QOL income statement (TTM) | |
---|---|
Revenue | €1.50b |
Cost of Revenue | €1.15b |
Gross Profit | €356.74m |
Other Expenses | €211.01m |
Earnings | €145.73m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.61 |
Gross Margin | 23.72% |
Net Profit Margin | 9.69% |
Debt/Equity Ratio | 56.0% |
How did QOL perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield23%
Payout RatioDoes QOL pay a reliable dividends?
See QOL dividend history and benchmarksSOL dividend dates | |
---|---|
Ex Dividend Date | May 20 2024 |
Dividend Pay Date | May 22 2024 |
Days until Ex dividend | 24 days |
Days until Dividend pay date | 26 days |
Does QOL pay a reliable dividends?
See QOL dividend history and benchmarks